Connect with us

Technology

AI-Driven Market Transformation, Europe’s Pharma E-Commerce to Grow by USD 38.7 Billion from 2024-2028, Boosted by Internet Accessibility

Published

on

NEW YORK, Oct. 1, 2024 /PRNewswire/ — Report with the AI impact on market trends- The global pharma e-commerce market in Europe size is estimated to grow by USD 38.7 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 16.27%  during the forecast period. Availability of internet provides convenience to consumers is driving market growth, with a trend towards growing acceptance in newly regulated european states. However, illegal and counterfeit trading of drugs through e-pharmacy  poses a challenge. Key market players include Ace Chemist Direct, apo rot GmbH, Apotea AB, Arzneiprivat, Atropa Pharmacy, Chemist4U Innox Trading Ltd., Dirk Rossmann GmbH, DocMorris AG, EURO PHARM International Canada Inc., Farmacia Campoamor, Juvalis, McKesson Corp., myCARE e.k, Parafarmacia online, Pharmacy2U Ltd., Redcare Pharmacy, The French Pharmacy, UK MEDS Direct Ltd., Walgreens Boots Alliance Inc., and Wort and Bild Verlag Konradshohe GmbH and Co. KG.

Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View the snapshot of this report

Pharma E-Commerce Market In Europe Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 16.27%

Market growth 2024-2028

USD 38.7 billion

Market structure

Fragmented

YoY growth 2022-2023 (%)

15.12

Regional analysis

Europe

Performing market contribution

Europe at 100%

Key countries

Germany, UK, France, Italy, and Rest of Europe

Key companies profiled

Ace Chemist Direct, apo rot GmbH, Apotea AB, Arzneiprivat, Atropa Pharmacy, Chemist4U Innox Trading Ltd., Dirk Rossmann GmbH, DocMorris AG, EURO PHARM International Canada Inc., Farmacia Campoamor, Juvalis, McKesson Corp., myCARE e.k, Parafarmacia online, Pharmacy2U Ltd., Redcare Pharmacy, The French Pharmacy, UK MEDS Direct Ltd., Walgreens Boots Alliance Inc., and Wort and Bild Verlag Konradshohe GmbH and Co. KG

Market Driver

Pharma e-commerce in Europe is witnessing significant growth due to the increasing demand for personalized medicine and health solutions. Leveraging data analytics and artificial intelligence, these platforms provide customized recommendations, treatment plans, and wellness programs based on individual preferences and health histories. Personalized medicine, which involves customizing medical treatment to each patient’s unique characteristics, is facilitated through a wide range of offerings, including specialty drugs and compounded medications. Patients can work with healthcare professionals to develop personalized treatment regimens and order necessary medications online. The trend extends beyond disease treatment to encompass wellness and preventive care, with e-commerce platforms offering health supplements, vitamins, and wellness products tailored to individual health goals. The European pharma e-commerce market is expected to grow, fueled by this trend and the innovation it inspires, including genetic testing services and health monitoring devices.

The European pharma e-commerce market is experiencing significant growth, with medications, medical supplies, and healthcare products leading the way. Remote healthcare services, such as telemedicine and e-prescriptions, are also trending, especially among the elderly population with chronic diseases. Consumer convenience and cost-effective solutions are key drivers, with many opting for online pharmacies and mail-order services. However, challenges persist, including counterfeit pharmaceuticals, data protection, and consumer trust. Healthcare systems and internet connectivity are essential for the success of digital healthcare solutions. Omnichannel retailing, including inventory data and logistics, is crucial for supply chain efficiency. Direct sales to healthcare professionals are also increasing. E-prescriptions and digital prescription services are becoming more common, but illegal and unregulated online pharmacies pose a threat to consumer safety. Quality assurance and regulatory compliance are essential to maintain consumer trust.

Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!

Market Challenges

The proliferation of counterfeit drugs in the European pharma e-commerce market poses a significant challenge. These drugs, sold through virtual platforms, undermine industry integrity and pose health risks due to incorrect ingredients or dosages. Illicit drugs such as cannabis, heroin, and cocaine are commonly traded. This globalized counterfeit drug trade increases societal threats, including drug-related crimes and fatalities from overdoses. E-commerce’s lack of regulation and oversight enables third-party sellers to exploit loopholes, making it difficult for authorities to monitor and control sales effectively. This situation negatively impacts the growth of the pharma e-commerce market in Europe, potentially hindering its forecasted expansion.The European pharma e-commerce market is experiencing significant growth due to an aging population and the rise of online and mail-order pharmacies. Challenges include managing chronic diseases, ensuring patient safety, and addressing illegal and unregulated online pharmacies. Digital prescription services and e-prescriptions are key trends, but logistics and inventory data management are crucial for success. Omnichannel retailing, including OTC medications and prescription medications, targets a large patient population. Health insurers and digital healthcare platforms are driving demand for electronic prescriptions and mobile applications. AI chatbots and machine learning enable personalized patient care, while data analytics and prescription refills enhance convenience. Cross-border e-commerce and drug counterfeiting pose risks, requiring strict regulation and biometric identification for security. The diabetes segment and immune-system diseases are major growth areas in the B2C market. Manufacturer-owned marketplaces and digital technologies are transforming the industry, offering new opportunities for growth.

Discover how AI is revolutionizing market trends- Get your access now!

Segment Overview 

This pharma e-commerce market in Europe report extensively covers market segmentation by

Product 1.1 Medications1.2 Health/wellness and nutrition1.3 Personal care and essentialsType 2.1 Rx2.2 OTCGeography 3.1 Europe

1.1 Medications-  The European pharma e-commerce market is experiencing significant growth due to the increasing demand for medications as the population ages and the prevalence of chronic diseases rises. Online pharmacies offer consumers the convenience of purchasing essential medications without visiting physical pharmacies, making it an attractive option for individuals with mobility issues, busy lifestyles, or those living in remote areas. These platforms provide access to a wide range of medications, including specialty drugs and rare medications, ensuring consumers have access to the necessary treatments regardless of their location. Additionally, online platforms offer valuable information on medication side effects, low-cost substitutes, and potential drug interactions, enabling consumers to make informed purchasing decisions. These factors contribute to the anticipated growth of the medications segment and the pharma e-commerce market in Europe during the forecast period.

Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics

Research Analysis

Pharma e-commerce in Europe is experiencing significant growth, driven by the increasing elderly population and the demand for convenient healthcare solutions. Online pharmacies and mail-order pharmacies are becoming popular, offering prescription medications, over-the-counter pharmaceuticals, and healthcare products. Telemedicine and digital prescription services enable remote healthcare consultations and electronic prescriptions. However, the rise of illegal online pharmacies poses a threat, selling counterfeit pharmaceuticals and compromising data protection. Two-factor authentication and data analytics help ensure security and personalized services. Mobile applications facilitate prescription refills and remote healthcare services. Artificial intelligence and data analytics improve patient care and optimize supply chain management. Overall, pharma e-commerce in Europe offers a wide range of digital platforms for medications, medical supplies, and healthcare products, enhancing consumer convenience and accessibility for chronic disease management and life expectancy improvement.

Market Research Overview

The Pharma E-Commerce Market in Europe is experiencing significant growth due to the increasing elderly population, chronic diseases, and advancements in digital healthcare. Online pharmacies and mail-order pharmacies are becoming increasingly popular, offering convenience and accessibility to patients. Telemedicine and e-prescriptions are also on the rise, enabling remote healthcare services and digital prescription services. However, the market also faces challenges such as illegal and unregulated online pharmacies, drug counterfeiting, and healthcare accessibility issues. Healthcare professionals, health insurers, and manufacturer-owned marketplaces are also playing key roles in this evolving landscape. Omnichannel retailing, inventory data management, logistics, and cost-effective solutions are essential for success in this market. Digital technologies, including AI chatbots, machine learning, and data analytics, are transforming the industry, offering personalized healthcare and consumer convenience. E-commerce platforms, mobile applications, prescription refills, and two-factor authentication are also driving growth in the B2C segment. Data protection and quality assurance are crucial for consumer trust, while cross-border e-commerce and medical tourism are expanding opportunities for growth. The market for prescription medications, OTC medications, medical supplies, and healthcare products is expected to continue growing, fueled by increasing healthcare expenses, internet penetration, and the need for cost-effective solutions.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

ProductMedicationsHealth/wellness And NutritionPersonal Care And EssentialsTypeRxOTCGeographyEurope

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/ai-driven-market-transformation-europes-pharma-e-commerce-to-grow-by-usd-38-7-billion-from-2024-2028–boosted-by-internet-accessibility-302262479.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

RiskBlue Launches Contract Management Software for Builder’s Risk and Water Mitigation Contracts

Published

on

By

RiskBlue introduces a transformative software solution to manage high-rise construction risks and streamline insurance processes.

LONDON, Oct. 2, 2024 /PRNewswire-PRWeb/ — RiskBlue, a new venture from RiskClock, announces the launch of its innovative contract management software, specifically designed to assist insurance brokers and developers in efficiently managing high-rise Builder’s Risk and Water Mitigation contracts. The platform aims to enhance water insurance risk control and management in the construction and operational property sectors.

Under the leadership of serial entrepreneur Diogo Beltran, RiskBlue delivers a user-friendly interface that offers the construction industry’s most reliable water risk controls, sourced from reputable providers. This ensures all parties involved in a project are aligned with the project’s controls and schedule, securing investments and enhancing management practices across the industry.

“Our goal at RiskBlue is to redefine the standard for risk management in construction and operational properties,” Diogo Beltran explained. “We are committed to bridging the gap between risk assessment and mitigation, providing a platform that ensures both are handled with the utmost efficiency and reliability.”

RiskBlue’s software facilitates streamlined underwriting processes for Builder’s Risk and Water Mitigation contracts by providing tools that help forecast, evaluate, and manage potential water-related hazards. This proactive approach aids in preventing delays and overruns, keeping projects within budget and on schedule.

“The construction sector often faces challenges with water-related risks that can derail projects. Our software provides a strategic advantage by integrating detailed risk evaluations and mitigation strategies into one central system,” added Beltran. “This allows stakeholders to maintain tight control over project timelines and budgets, significantly reducing the risk of costly setbacks.”

The platform not only serves as a critical tool for insurance brokers and developers but also fosters a collaborative environment by connecting them with leading solution providers. This collaboration ensures that all mitigation strategies are comprehensive and tailored to the specific needs of each project.

RiskBlue is now available for industry professionals who are looking to enhance their risk management capabilities and protect their construction and operational investments from water-related risks.

For additional details on how RiskBlue can transform your approach to managing construction risks and to schedule a demo, please visit https://www.riskblue.com.

About RiskClock

Established by Diogo Beltran, RiskClock is renowned for its innovation in construction technology, focusing on pioneering solutions that enhance the safety and efficiency of construction and operational projects. RiskClock continues to lead the way in developing cutting-edge technology solutions for the industry.

Media Contact

Diogo Beltran, RiskBlue, 888-888-8888, diogo.beltran@riskclock.com, https://www.riskblue.com/

View original content to download multimedia:https://www.prweb.com/releases/riskblue-launches-contract-management-software-for-builders-risk-and-water-mitigation-contracts-302265097.html

SOURCE RiskBlue

Continue Reading

Technology

Skanska signs supplemental award for data center in Georgia, USA, for USD 80M, about SEK 840M

Published

on

By

STOCKHOLM, Oct. 2, 2024 /PRNewswire/ — Skanska has received a supplemental award with an existing client to build additional data halls at a data center in Georgia, USA. The supplemental award is worth USD 80M, about SEK 840M, which will be included in the US order bookings for the third quarter of 2024.

The project is the construction of four additional data halls on a previous data center site in Georgia.

Work is underway and is scheduled for completion in the third quarter of 2025.

For further information please contact:

Ashley Jeffery, Communications Mgr, Skanska USA Building, tel +1 813 459 3682

Andreas Joons, Press Officer, Skanska AB, tel +46 (0)10 449 04 94

Direct line for media, tel +46 (0)10 448 88 99

This and previous releases can also be found at www.skanska.com.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/skanska/r/skanska-signs-supplemental-award-for-data-center-in-georgia–usa–for-usd-80m–about-sek-840m,c4045660

The following files are available for download:

https://mb.cision.com/Main/95/4045660/3033638.pdf

20241002 US data center addition

 

View original content:https://www.prnewswire.com/news-releases/skanska-signs-supplemental-award-for-data-center-in-georgia-usa-for-usd-80m-about-sek-840m-302265265.html

SOURCE Skanska

Continue Reading

Technology

Fractus expands IoT patent licensing program signing ADT agreement and ending litigation

Published

on

By

BARCELONA, Spain, Oct. 2, 2024 /PRNewswire/ — Fractus, a leader in in antenna technology and IP licensing, announced today the successful signing of a patent licensing agreement with ADT, the market leader in connected alarm systems in the United States. With this agreement, Fractus continues to assert its leadership in IP and antenna technology, further strengthening its position in the rapidly evolving Internet of Things (IoT) sector.

Fractus has achieved a significant milestone by securing a new licensing agreement with ADT, following a patent infringement lawsuit it filed in October 2022 against both ADT and Vivint (case 2:22-cv-00412-JRG and 2:22-cv-00413-JRG) over internal antenna technology critical to alarm security systems. This deal, which adds to the agreement reached earlier this year with Vivint, consolidates Fractus’ position as a key technology provider in the Internet of Things (IoT) market. By expanding its base of licensees within the IoT ecosystem, Fractus reaffirms its commitment to protecting and monetizing its intellectual property.

“We are proud to announce this significant agreement with ADT,” said Jordi Ilario, COO and VP at Fractus. “The IoT landscape is diverse and fragmented, but we remain focused and resilient in leveraging our patent portfolio. This agreement is a testament to our ongoing efforts to drive revenue through IoT licensing and explore new areas of development.”

“Our success in sectors such as network infrastructure and mobile phone OEMs underscores the value of our innovations,” said Ruben Bonet, CEO of Fractus. “The progress we’ve made this year positions us optimistically for future growth and further expansion within the IoT sector.”

Fractus was represented by the top-tier law firm Susman Godfrey. “We are pleased to continue our more than decade-long history of successfully representing Fractus, which stretches back to 2011 with a jury verdict in favor of Fractus against Samsung,” said Max Tribble, a Susman Godfrey lawyer.

About Fractus

Fractus is an early pioneer in developing antenna technology for smartphones, tablets and other wireless Internet of Things devices and holds an intellectual property rights portfolio of more than 40 inventions protected through over 120 patents and patent applications in the United States, Europe and Asia. Among the numerous awards and honors the company has received for its innovative work, Fractus was named a 2005 Davos World Economic Forum Technology Pioneer and one of Red Herring’s top innovative companies for 2006. It also won the 2004 Frost & Sullivan Award for technological innovation and the 2010 National Communication Award of the Catalan Government in the telecommunications category. A team of Fractus inventors was finalist for the EPO European Inventor Award 2014. On November 2015, Fractus was awarded Academiae Dilecta by the Spanish Royal Engineering Academy and on April 2017 received the “European Inspiring Company Award” by the London Stock Exchange and the Elite Group.

Logo – https://mma.prnewswire.com/media/1896932/Fractus_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/fractus-expands-iot-patent-licensing-program-signing-adt-agreement-and-ending-litigation-302264328.html

Continue Reading

Trending